Effect of melatonin on gut microbiome and metabolomics in diabetic cognitive impairment
Our results supported the use of MEL as a promising therapeutic agent for DCI, in which the underlying mechanism may be associated with gut microbiome and metabolomics regulation.
Authors
- B X Zhang (ORCID: https://orcid.org/0009-0004-4757-4957)
- Jiadong Lang
- Qiangqiang Zhang (ORCID: https://orcid.org/0000-0002-6082-6782)
- Ming Gao (ORCID: https://orcid.org/0000-0002-2743-2247)
- Jinting Chen (ORCID: https://orcid.org/0000-0001-5475-0155)
- Xu Han (ORCID: https://orcid.org/0000-0003-0060-1343)
- Jie Li (ORCID: https://orcid.org/0000-0002-1558-8623)
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
- Hebei Provincial Department of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3389/fphar.2024.1489834
- Citations
- 4
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 1.31